Astragalus root induces ovarian β‑oxidation and suppresses estrogen‑dependent uterine proliferation

Orkhon,Banzragchgarav; Kobayashi,Kyoko; Javzan,Batkhuu; Sasaki,Kenroh

doi:10.3892/mmr.2018.9493

Astragalus root induces ovarian β‑oxidation and suppresses estrogen‑dependent uterine proliferation

Authors:
- Banzragchgarav Orkhon
- Kyoko Kobayashi
- Batkhuu Javzan
- Kenroh Sasaki
View Affiliations

Affiliations: Department of Pharmacognosy, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981‑8558, Japan, School of Engineering and Applied Sciences, National University of Mongolia, Ulaanbaatar 14201, Mongolia
Published online on: September 19, 2018 https://doi.org/10.3892/mmr.2018.9493
Pages: 5198-5206

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Continuous estrogen stimulation in the uterus has been known to cause excess proliferation of the functional layer of endometrium, resulting in endometrial hyperplasia and leading to infertility. Estrogens can modulate other nuclear receptor signaling pathways, such as peroxisome proliferator‑activated receptors (PPARs). Astragalus root (AsR) has exhibited strong PPARα agonistic activity. Female Imprinting Control Region mice were fed a powder diet that included 5% AsR hot water extract or 0.1% bezafibrate as a positive control for 56 days to investigate AsR effects on the reproductive tract, ovary and uterus. AsR resulted in upregulation of the expression of uterine and ovarian PPARα mRNA by 2.5‑fold, and 1.5‑fold, respectively, compared with controls. AsR significantly increased ovarian expression levels of mitochondrial 2,4‑dienoyl‑CoA reductase (mDECR), an auxiliary enzyme involved in β‑oxidation. AsR‑fed mice also exhibited a significant increase in blood estradiol levels and tended to have higher ovary weight. AsR resulted in significantly decreased uterine weight and mDECR expression levels. It has been reported that a PPARα agonist suppresses the development of estrogen‑dependent endometrial hyperplasia. These findings raise the possibility that AsR suppresses estrogen‑dependent endometrial hyperplasia and ovarian dysfunction leading to infertility.

View Figures

View References

1	Llorens MA, Bermejo MJ, Salcedo MC, Charro AL and Puente M: Epidermal growth factor receptors in human breast and endometrial carcinomas. J Steroid Biochem. 34:505–509. 1989. View Article : Google Scholar : PubMed/NCBI
2	Niikura H, Sasano H, Kaga K, Sato S and Yajima A: Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum Pathol. 27:282–289. 1996. View Article : Google Scholar : PubMed/NCBI
3	Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM and Walker CL: Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res. 63:1221–1227. 2003.PubMed/NCBI
4	Braissant O, Foufelle E, Scotto C, Dauça M and Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 137:354–366. 1996. View Article : Google Scholar : PubMed/NCBI
5	Zhao Y, Tan YS, Strynar MJ, Perez G, Haslam SZ and Yang C: Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice. Reprod Toxicol. 33:563–576. 2012. View Article : Google Scholar : PubMed/NCBI
6	Mitchell DC and Ing NH: Estradiol stabilizes estrogen receptor messenger ribonucleic acid in sheep endometrium via discrete sequence elements in its 3′-untranslated region. Mol Endocrinol. 17:562–574. 2003. View Article : Google Scholar : PubMed/NCBI
7	Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F and Andó S: Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res. 11:6139–6147. 2005. View Article : Google Scholar : PubMed/NCBI
8	Mu YM, Yanase T, Nishi Y, Takayanagi R, Goto K and Nawata H: Combined treatment with specific ligands for PPARgamma: RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol Cell Endocrinol. 181:239–248. 2001. View Article : Google Scholar : PubMed/NCBI
9	Wang QH, Han N, Dai N, Wang X and Ao W: Anti-inflammatory effects and structure elucidation of two new compounds from Astragalus membranaceus (Fisch) Bge. var. mongholicus (Bge) Hsiao. J Mol Struc. 1074:284–288. 2014. View Article : Google Scholar
10	No authors listed: Astragalus membranaceus. Monograph. Altern Med Rev. 8:72–77. 2003.PubMed/NCBI
11	Chen J, Ge B, Wang Y, Ye Y, Zeng S and Huang Z: Biochanin A promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in breast cancer cells. Cell Physiol Biochem. 35:639–646. 2015. View Article : Google Scholar : PubMed/NCBI
12	Tohda C, Tamura T, Matsuyama S and Komatsu K: Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br J Pharmacol. 149:532–541. 2006. View Article : Google Scholar : PubMed/NCBI
13	Kitagawa I, Wang HK, Saito M, Takagi A and Yoshikawa M: Saponin and sapogenol. XXXV. Chemical constituents of Astragali radix, the root of Astragalus membranaceus BUNGE. (2). Astragalosides I, II and IV, Acetylastragaloside I and isoastragalosides I and II. Chem Pharm Bull. 31:698–708. 1983. View Article : Google Scholar
14	Luo HL, Zhong J, Ye FY, Wang Q, Ma YM, Liu P, Zhang H, Sunc MY and Jiang J: A systematic quality control method of Huangqi decoction: Simultaneous determination of eleven flavonoids and seven triterpenoid saponins by UHPLC-MS. Anal Methods. 6:4593–4601. 2014. View Article : Google Scholar
15	Wang X, Wang Y, Hu JP, Yu S, Li BK, Cui Y, Ren L and Zhang LD: Astragaloside IV, a natural PPARγ agonist, reduces Aβ production in Alzheimer's disease through inhibition of BACE1. Mol Neurobiol. 54:2939–2949. 2017. View Article : Google Scholar : PubMed/NCBI
16	Jiang K, Lu Q, Li Q, Ji Y, Chen W and Xue X: Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol. 42:195–202. 2017. View Article : Google Scholar : PubMed/NCBI
17	Wang PP, Xu DJ, Huang C, Wang WP and Xu WK: Astragaloside IV reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines. Mol Med Rep. 9:2131–2137. 2014. View Article : Google Scholar : PubMed/NCBI
18	Cheng X, Gu J, Zang M, Yuan J, Zhao B, Jiang J and Jia X: Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway. Int Immunopharmacol. 23:304–313. 2010. View Article : Google Scholar
19	Kobayashi K, Matsuyama W, Arai Y, Koizumi S, Shimizu T, Tomioka R and Sasaki K: Boiogito increases the metabolism of fatty acids in proximal tubular cells through peroxisome proliferators-activated receptor (PPAR) α agonistic activity. Biol Pharm Bull. 39:143–147. 2016. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Dommes V, Baumgart C and Kunau WH: Degradation of unsaturated fatty acids in peroxisomes. Existence of a 2,4-dienoyl-CoA reductase pathway. J Biol Chem. 256:8259–8262. 1981.PubMed/NCBI
22	Hakkola EH, Autio-Harmainen HI, Sormunen RT, Hassinen IE and Hiltunen JK: The known purified mammalian 2,4-dienoyl-CoA reductases are mitochondrial isoenzymes. J Histochem Cytochem. 37:1863–1867. 1989. View Article : Google Scholar : PubMed/NCBI
23	Rak-Mardyła A and Drwal E: In vitro interaction between resistin and peroxisome proliferator-activated receptor γ in porcine ovarian follicles. Reprod Fertil Dev. 28:357–368. 2016. View Article : Google Scholar : PubMed/NCBI
24	Willson TM, Brown PJ, Sternbach DD and Henke BR: The PPARs: From orphan receptors to drug discovery. J Med Chem. 43:527–550. 2000. View Article : Google Scholar : PubMed/NCBI
25	Wang T, Zhang M, Jiang Z and Seli E: Mitochondrial dysfunction and ovarian aging. Am J Reprod Immunol. 77:e126512017. View Article : Google Scholar
26	Keller H, Givel F, Perroud M and Wahli W: Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol. 9:794–804. 1995. View Article : Google Scholar : PubMed/NCBI
27	Dassen H, Punyadeera C, Delvoux B, Schulkens I, Marchetti C, Kamps R, Klomp J, Dijcks F, de Goeij A, D'Hooghe T, et al: Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling. Am J Pathol. 177:2495–2508. 2010. View Article : Google Scholar : PubMed/NCBI
28	Gunin AG, Bitter AD, Demakov AB, Vasilieva EN and Suslonova NV: Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. J Endocrinol. 182:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
29	Kurman RJ, Kaminski PF and Norris HJ: The behavior of endometrial hyperplasia. A long-term study of ‘untreated’ hyperplasia in 170 patients. Cancer. 56:403–412. 1985. View Article : Google Scholar : PubMed/NCBI
30	Lindahl B and Willén R: Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years. Anticancer Res. 14:2141–2146. 1994.PubMed/NCBI
31	Truman AM, Tilly JL and Woods DC: Ovarian regeneration: The potential for stem cell contribution in the postnatal ovary to sustained endocrine function. Mol and Cell Endocrinol. 445:74–84. 2017. View Article : Google Scholar
32	Erler P, Sweeney A and Monaghan JR: Regulation of injury-induced ovarian regeneration by activation of Oogonial stem cells. Stem Cells. 35:236–247. 2017. View Article : Google Scholar : PubMed/NCBI